Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
2024 ChemOutsourcing
Know what’s ahead with Thermo Fisher Scientific’s CDMO services and solutions for small molecule APIs.
September 3-6, 2024 | Parsippany, New Jersey | Booth #24
About 2024 ChemOutsourcing
ChemOutsourcing is the largest U.S.-based event for active pharmaceutical ingredients (APIs), drawing 700-800 customers annually from the pharmaceutical, biotech, and chemistry services sectors across 30 countries. The show covers the entire API development supply chain, including raw materials, catalysts, drug discovery, and manufacturing, and attracts executive-level buyers and suppliers alike.
As the best-established and longest-running pharmaceutical ingredients show in the U.S., ChemOutsourcing offers suppliers exhibit booths and private meeting rooms to connect with customers face to face. The event features pre-show access to attendee lists and a portal for arranging meetings, complemented by three consecutive evening beach parties to enhance networking opportunities.
Event details
Date: September 3-6, 2024
Format: In person
Location: Parsippany, New Jersey
Booth number: #24
Event website: https://www.chemoutsourcing.com/
Exhibitor page: Click here.
Why Thermo Fisher Scientific?
Thermo Fisher Scientific played a key role in developing and manufacturing 16% of all FDA-approved small molecules in 2023, and 21% in 2022. As an industry-leading CDMO for biotechnology and pharmaceutical companies, we’ll educate your team on what’s ahead. By partnering with us, you can know your regulatory landscape. Know potential issues to overcome. Know API development challenges. Know your project’s likelihood of success. You can trust us — we’ve been down this road before. Together, we can help smooth your path to approval.
Please fill out the form below, including the topic you are interested in, and we will be in touch.
Let’s connect at 2024 ChemOutsourcing
Visit Thermo Fisher Scientific at booth #24 during ChemOutsourcing to explore our end-to-end CDMO services and solutions for active pharmaceutical ingredients (APIs).
With over 50 years of experience in the small molecule space, we can support every step of your journey — from early development to commercial manufacturing.